[ Price : $8.95]
FDA grants Keros Therapeutics an orphan drug designation for its investigational therapy KER-065 and its use in treating Duchenne ...[ Price : $8.95]
FDA announces a 10/23 public workshop to discuss the regulatory status of, and potential alternatives to, patch tests used in diag...[ Price : $8.95]
Nucleus RadioPharma appoints former FDA commissioner Stephen Hahn (Trump Administration 2019-2021) as its chief executive officer.[ Price : $8.95]
FDA issues enVVeno Medical a not-approvable letter for its PMA on VenoValve, a surgical replacement venous valve designed to treat...[ Price : $8.95]
FDA lifts a clinical hold on Rocket Pharmaceuticals pivotal Phase 2 trial of RP-A501, an investigational gene therapy for Danon di...[ Price : $8.95]
Experts share varying opinions with Clinical Trials Arena on the impact of an FDA rule barring biotech companies from sending cell...[ Price : $8.95]
Some 750 current and former HHSers call on secretary Robert F. Kennedy, Jr., to protect them and the rest of his staff from attack...[ Price : $8.95]
Updated medical device breakthrough device designation metrics show 1,176 approvals since 2015 and 160 marketing authorizations.